alexa Abstract | One Hundred Years of Heparin
ISSN: 2329-8790

Journal of Hematology & Thromboembolic Diseases
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Opinion Article Open Access


This year is the 100th anniversary of the discovery of heparin, the main anticoagulant drugs for more than 70 years [1], and we would like to remind its discovery. Heparin is a highly-sulfated glycosaminoglycan. It was first discovered by J McLean and WH Howell. McLean was a second-year medical student, at Johns Hopkins University, who was assisting Howell in the investigation of procoagulant preparations. Howell sugggestd to him that he study the nature of the thromboplastic substance to identify the active principle of this extract. In 1916 the young student isolated a fat-soluble anticoagulant in canine liver tissue [2]. It was discovered serendipitously in the course of a problem.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Gargantilla P, Arroyo N and Pintor E


Anticoagulants Drugs

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version